Brokerages Set CryoPort, Inc. (NASDAQ:CYRX) Target Price at $12.83

CryoPort, Inc. (NASDAQ:CYRX) has been assigned a consensus rating of “Moderate Buy” from the ten analysts that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and eight have given a buy recommendation to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $12.8333.

CYRX has been the topic of a number of recent analyst reports. UBS Group raised their price target on CryoPort from $11.00 to $12.50 and gave the company a “buy” rating in a report on Wednesday, November 5th. Weiss Ratings reissued a “sell (d+)” rating on shares of CryoPort in a research note on Monday, December 29th. Finally, Needham & Company LLC boosted their price target on CryoPort from $11.00 to $12.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th.

Insider Activity

In other news, Director Ramkumar Mandalam sold 11,570 shares of the business’s stock in a transaction on Wednesday, December 10th. The shares were sold at an average price of $9.99, for a total value of $115,584.30. Following the transaction, the director owned 80,758 shares of the company’s stock, valued at approximately $806,772.42. The trade was a 12.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 10.00% of the stock is currently owned by insiders.

Institutional Trading of CryoPort

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. LPL Financial LLC lifted its stake in CryoPort by 6.6% in the 4th quarter. LPL Financial LLC now owns 23,306 shares of the company’s stock worth $224,000 after purchasing an additional 1,433 shares in the last quarter. The Manufacturers Life Insurance Company increased its holdings in shares of CryoPort by 9.4% in the second quarter. The Manufacturers Life Insurance Company now owns 18,178 shares of the company’s stock worth $136,000 after purchasing an additional 1,557 shares during the last quarter. Nisa Investment Advisors LLC lifted its position in shares of CryoPort by 299.9% in the second quarter. Nisa Investment Advisors LLC now owns 3,639 shares of the company’s stock worth $27,000 after buying an additional 2,729 shares in the last quarter. State of Wyoming boosted its stake in CryoPort by 30.2% during the second quarter. State of Wyoming now owns 14,218 shares of the company’s stock valued at $106,000 after buying an additional 3,301 shares during the last quarter. Finally, Intech Investment Management LLC boosted its stake in CryoPort by 14.6% during the second quarter. Intech Investment Management LLC now owns 25,951 shares of the company’s stock valued at $194,000 after buying an additional 3,305 shares during the last quarter. 92.90% of the stock is currently owned by institutional investors.

CryoPort Price Performance

Shares of NASDAQ:CYRX opened at $8.42 on Thursday. The company has a market capitalization of $421.59 million, a P/E ratio of 7.20 and a beta of 1.66. CryoPort has a 1-year low of $4.58 and a 1-year high of $11.45. The firm’s 50 day simple moving average is $9.57 and its two-hundred day simple moving average is $9.41. The company has a debt-to-equity ratio of 0.40, a current ratio of 15.77 and a quick ratio of 15.01.

About CryoPort

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.